Protagonist Therapeutics (PTGX) Earnings
|
Expand Research on PTGX
| Next EPS Date | 11/6/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +31.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | $2.29 | $2.13 | +$0.16 | $213.47M | $190.12M | N/A |  | | Details | |
| 5/5/26 |
Q126 | $0.05 | -$0.49 | +$0.54 | $56.37M | $12.2M | N/A | | | Details | |
| 3/18/26 |
Q425 | N/A | -$0.34 | N/A | N/A | $26.81M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.62 | -$0.63 | +$0.01 | $4.71M | $4.51M | N/A | | | Details | |
| 8/6/25 | Q225 | -$0.55 | -$0.58 | +$0.03 | $5.55M | $7.51M | N/A | | | Details | |
| 8/4/25 |
Q225 | N/A | -$0.58 | N/A | N/A | $7.51M | N/A | N/A | N/A | ||
| 7/31/25 |
Q225 | N/A | -$0.58 | N/A | N/A | $7.51M | N/A | N/A | N/A | ||
| 5/12/25 |
Q125 | N/A | -$0.06 | N/A | N/A | $39.92M | N/A | N/A | N/A |
